Access to Substance Abuse Treatment Act of 2013
A BILL
To amend the Public Health Service Act to provide grants for treatment of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP) abuse, and for other purposes.
Sec. 2 Purpose
Sec. 3 Heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP) treatment and wrap-around programs
“514C. Initiative to increase heroin, cocaine, methamphetamine, ecstasy, and PCP treatment capacity
“(a) In general—The Secretary may make grants to State, local, and tribal governments for the purpose of increasing the availability of treatment for heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP) abuse.
“(b) Requirements
“(1) In general—To seek a grant under subsection (a), a State, local, or tribal government shall submit an application to the Secretary at such time, in such manner, and containing such information and assurances as the Secretary may require.
“(2) Use of grant funds—The grants made under subsection (a) may only be used to—
“(A) build treatment centers;
“(B) expand existing treatment centers;
“(C) hire treatment professionals;
“(D) provide training and education to substance abuse professionals, medical professionals, and educators related to the treatment of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and phencyclidine abuse; and
“(E) engage in other activities that the Secretary has determined are relevant to the purpose of the grants under subsection (a).
“(c) Authorization of appropriations—There are authorized to be appropriated such sums as may be necessary to carry out this section for fiscal years 2014 through 2018.
“514D. Heroin, cocaine, methamphetamine, ecstasy, and PCP abuse treatment vouchers for underserved populations
“(a) In general—The Secretary may make grants to State, local, and tribal governments and nonprofit entities to provide vouchers to individuals in underserved populations for authorized services related to the treatment of such individuals for heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP) abuse.
“(b) Requirements
“(1) Application—To seek a grant under subsection (a), a State, local, or tribal government or a nonprofit entity shall submit an application to the Secretary at such time, in such manner, and containing such information and assurances as the Secretary may require, including a description of the method that such State, government, or entity will use—
“(A) to identify individuals who would benefit from treatment for heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, or phencyclidine abuse;
“(B) to identify if such individuals are in underserved populations; and
“(C) to provide vouchers to such individuals in such populations.
“(2) Preservation of choice—A recipient of a grant under this section may not restrict the ability of an individual receiving a voucher under this section to use the voucher to pay for authorized services furnished by any provider of authorized services, so long as the provider of such services meets all applicable State licensure or certification requirements regarding the provision of such services.
“(3) Duration of award—With respect to a grant under this section, the period during which payments under such grant are made to the grant recipient may not exceed five years.
“(4) Matching funds—The Secretary may require that recipients of grants under this section provide non-Federal matching funds, as determined appropriate by the Secretary, to ensure the commitment of the grant recipients to the provision of vouchers for treatment to individuals who use heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, or phencyclidine. Such non-Federal matching funds may be provided directly or through donations from public or private entities and may be in cash or in-kind, fairly evaluated, including property, equipment, or services.
“(5) Maintenance of effort—The Secretary may require that grant recipients under this section agree to maintain expenditures of non-Federal amounts for authorized services related to the treatment of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and phencyclidine abuse at a level that is not less than the level of such expenditures maintained by the recipient for the fiscal year preceding the fiscal year for which the entity receives such a grant.
“(c) Report
“(1) In general—Not later than December 1, 2014, and annually thereafter, the Secretary shall submit a report to the Congress on the grants under subsection (a).
“(2) Contents of report—The report under paragraph (1) shall contain an evaluation of the effectiveness of the grants made under subsection (a) in improving access to heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and phencyclidine treatment for underserved populations.
“(d) Definitions—For purposes of this section:
“(1) Authorized services—The term authorized services means—
“(A) treatment for heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, or phencyclidine abuse, including individual, group, and family counseling regarding such abuse;
“(B) follow-up services to prevent an individual from relapsing into such abuse;
“(C) wrap-around services, as such term is defined in section 514E(e)(4); and
“(D) any additional services specified by the Secretary.
“(2) Underserved population—The term underserved population means a population of individuals who cannot access appropriate substance abuse treatment (including comprehensive substance abuse treatment) due to financial, geographical, language, socioeconomic, or cultural barriers.
“(e) Authorization of appropriations—There are authorized to be appropriated such sums as may be necessary to carry out this section for fiscal years 2014 through 2018.
“514E. Comprehensive wrap-around heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine (ecstasy), and phencyclidine (PCP) treatment services
“(a) In general—The Secretary may make grants to public, private, and nonprofit entities, Indian tribes, and tribal organizations to establish programs to provide for and coordinate the provision of wrap-around services to heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, or phencyclidine-affected individuals.
“(b) Minimum qualifications for receipt of award—To seek a grant under subsection (a), a public, private, or nonprofit entity, an Indian tribe, or a tribal organization shall submit an application to the Secretary at such time, in such manner, and containing such information and assurances as the Secretary may require, including assurances to the satisfaction of the Secretary that—
“(1) the applicant has the capacity to carry out a program described in subsection (a);
“(2) the applicant has entered into agreements with entities in the community involved, through which the applicant will provide wrap-around services; and
“(3) the applicant, or any entity through which the applicant will provide such services, meets all applicable State licensure or certification requirements regarding the provision of such services.
“(c) Priority for grant distribution—In making grants under this section, the Secretary shall give priority to applications for programs that serve communities with a high or increasing rate of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, or phencyclidine abuse or addiction, as specified by the Secretary.
“(d) Reports—For each year that a public, private, or nonprofit entity, Indian tribe, or tribal organization receives a grant under subsection (a) for a program, such entity, tribe, or organization shall submit to the Secretary a report on the results and effectiveness of the program.
“(e) Definitions—For purposes of this section:
“(1) Heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, or phencyclidine-affected individual—The term heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, or phencyclidine-affected individual means an individual who—
“(A)
“(i) resided in a residential inpatient treatment facility for the treatment of heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, or phencyclidine abuse or addiction; or
“(ii) received treatment for heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, or phencyclidine abuse or addiction from an intensive outpatient treatment facility; and
“(B) after successful completion of such treatment reenters the community.
“(2) Intensive outpatient treatment facility—The term intensive outpatient treatment facility means a facility that provides treatment for substance abuse and that, with respect to an individual receiving such treatment—
“(A) provides a minimum of seven hours of treatment for substance abuse during a week;
“(B) provides regularly scheduled treatment sessions within a structured program; and
“(C) ensures that the treatment sessions are led by health professionals or clinicians.
“(3) Residential inpatient treatment facility—The term residential inpatient treatment facility means a facility that provides treatment for substance abuse in which health professionals and clinicians provide a planned regimen of 24-hour professionally directed evaluation, care, and treatment for such substance abuse in an inpatient setting, including 24-hour observation and monitoring.
“(4) Wrap-around services—The term wrap-around services means, with respect to a heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, or phencyclidine-affected individual, the following services:
“(A) Medical services.
“(B) Dental services.
“(C) Mental health services.
“(D) Child care services.
“(E) Job training services.
“(F) Housing assistance.
“(G) Training in parenting.
“(H) Prevention services for family members, with respect to heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, and phencyclidine abuse or addiction.
“(I) Transportation assistance services for purposes of participation in the services listed in subparagraphs (A) through (H).
“(f) Authorization of appropriations—There are authorized to be appropriated such sums as may be necessary to carry out this section for fiscal years 2014 through 2018.”
Sec. 4 Extension and expansion of residential treatment program for pregnant and postpartum women to include caregiver parents
“(m) Use of funds; Priority for certain areas served
“(1) Use of funds—A funding agreement for an award under subsection (a) for an applicant is that funds awarded under subsection (a) to such applicant shall be used for programs according to the following order of priority:
“(A) For a program that provides services to caregiver parents who are pregnant and postpartum women.
“(B) For a program that provides services to caregiver parents who are single parents and the sole caregivers with respect to their children.
“(C) For a program that provides services to any caregiver parents.
“(2) Priority for certain areas served—In making awards under subsection (a), the Director shall give priority to any entity, tribe, or organization that agrees to use the award for a program serving an area that—
“(A) is an area determined by the Director to have a shortage of family-based substance abuse treatment options; or
“(B) is determined by the Director to have high rates of addiction to heroin, cocaine, methamphetamine, 3,4-methylenedioxymethamphetamine, or phencyclidine.”
“(2) The term caregiver parent means, with respect to a child, a parent or legal guardian with whom the child resides, and includes a pregnant woman.”
“(3) The term eligible caregiver parent means a caregiver parent who has been admitted to a program operated pursuant to subsection (a).”